九福来

The listing of Jufeel was ascertained, and the SEC approved the issuance of 2.5 million new shares after 20 years of painstaking efforts

  • Categories:News
  • Time of issue:1577988600000

The listing of Jufeel was ascertained, and the SEC approved the issuance of 2.5 million new shares after 20 years of painstaking efforts

  • Categories:News
  • Time of issue:2020-01-03 02:10
Recently, reporters learned from the official website of the Securities and Exchange Commission (SEC) that the SEC has finally approved the initial public offering of new shares by CNJG on October 22, 2019. According to the securities law of the United States, the Securities and Exchange Commission (SEC) approved the first offering of 2.5 million new shares by CNJG, which has been published on the official website of the securities and Exchange Commission.
 
 
This is the first reply from SEC after several rounds of reviews since the application of S-1 form by Jufeel on March 29, 2019.
 
At present, the total share capital of CNJG is 28.03 million shares. After the issuance of new shares, the total share capital is 30.53 million shares. According to the financial quarterly report on September 30, the current earnings per share is $0.18.
 
It took CNJG nearly three years to obtain the SEC's approval to issue new shares. This is the 20th year since the founder of Jufeel, Zhang Rongxuan, set foot in aloe industry in 1999. Zhang Rongxuan himself has turned from a young man in his 30s to a middle-aged man who knows his destiny at the age of 53.
 
"After 20 years of unwavering efforts, I finally stepped onto the stage of international capital to display our strength. Thank all partners of Jufeel for their unremitting support over the past 20 years." Zhang Rongxuan, chairman of the board of directors of Jufeel International Co., Ltd said with deep emotion.
 
 
It was in November 2019, Zhang Rongxuan and the company's executives went to the United States for a road show, from the NYSE VIP Hall to the Trump Tower conference room, to the Microsoft Centre, meet with several American institutional investors, Israeli Jewish rich businessmen and overseas fund executives for several consecutive days. International investment institutions have expressed great interest in Aloe Vera enterprises from the East for 20 years and their dedicated and perfect large health industry chain. They are surprised and exclaimed that Jufeel uses purified PMAS from Aloe Vera to treat AIDS (HIV) patients in Tanzania, East Africa.
 
 
Professor Zhang Rongxuan was also invited to participate in the keynote speech on "global health and population intervention medicine" hosted by the Institute of population health implementation science of New York University, Germany International Science Award winner, Professor of Alexander von Humboldt University and director of Heidelberg Institute of public health.
 
Dr. Barneghausen's research focuses on the detection and development of population health interventions to address the medical needs of AIDS and other chronic diseases in poor countries. His research direction coincides with that of Jufeel international, which is committed to using PMAS to treat HIV acquired immunodeficiency syndrome.
 
On November 26, 2019, New York time, the introduction of CNJG was displayed on the large screen of NASDAQ Stock Exchange in times square of the United States for 15 minutes. 
 
 
New York Times Square, as the most attractive commercial "Golden advertising area" in the world, is not a false name, but the most real embodiment of value. Among them, the NASDAQ semi cylindrical giant screen is one of the most remarkable landmark buildings, known as the "world's first screen", which has always been the show of the world's companies. Famous Chinese companies Baidu, Huawei and Ant financial are all here to convey the image of China's excellent brands to the world.
 
 
As a pioneer enterprise in aloe industry in China, Jufeel has long been committed to aloe organic planting, aloe raw material processing, aloe biological extraction and aloe in-depth research and development, occupying the leading high-end raw material market in aloe industry in China. At present, Jufeel has completed the construction of a complete aloe industry chain, including 1850 Mu natural organic planting base in Hainan, aloe raw material processing and extraction center, product production center, Zhengzhou National Marketing Center, Kaifeng PMAS product production base, Jufeel Changzhou University Research Center, Taiwan joint research and development center, and has China, the United States and Hong Kong A number of technological invention patents, some of which have passed the examination of the international patent Union (PCT), have reached the international leading level.
 
The reporter learned that the reason why Jufeel has attracted the attention of international capital is the contribution of the company's R & D team in AIDS treatment. The company cooperates with famous universities and medical institutions such as Nanjing University of traditional Chinese medicine, School of pharmaceutical and life sciences of Changzhou University, Chung Shan Medical University of Taiwan, General Hospital of the people's Liberation Army (301 Hospital), etc. in R & D and clinical research, constantly breakthroughs in technology and repeatedly wins international awards. Among them, the "world outstanding invention award of AIDS prevention technology" issued by the World AIDS organization (WAOUN) of the United Nations; "The 46th Geneva International Exhibition of Inventions of Geneva medical health Gold Award" and other honors, and in the "20th Thailand AIDS and infectious diseases International Security Seminar" won the world's three famous universities Oxford University, Strasbourg University, France, the University of California, the United States jointly awarded the honorary certificate of technical recognition.
 
 
Jufeel has donated $5.3 million and $5 million worth of pure PMAS to Tanzania for clinical trials of AIDS treatment in Tanzania's National Medical Research Institute and its ten affiliated hospitals. The amazing therapeutic effect of PMAS on HIV caused a sensation in the Ministry of health and Tanzania Food and Drug Administration. Mr. Igogo, special economic adviser to the president of Tanzania, visited the headquarters of Jufeel International Group in September 2018 and December 2019 respectively. He paid special tribute to Professor Zhang Rongxuan, the international patent holder of PMAS technology and chairman of the board of directors of Jufeel International Group, and brought the clinical reports on the treatment of aids with PMAS in several hospitals in Tanzania. Appreciated Professor Zhang Rongxuan for his medical and health services to Tanzania. According to TFDA, PMAS batch number has passed the preliminary examination and will soon get the official certificate. 
 
 
In addition, according to the Jufeel natural medicine research center of Changzhou University, the research team led by Professor Zhang Rongxuan of the school of pharmaceutical and life sciences of Changzhou University and the scientific research project cooperated with the PLA General Hospital (301 Hospital), "the effect of Aloe Vera PMAS on the symptoms and antioxidant level of climacteric syndrome" was published in the core journal of science and technology, China food and nutrition, issue 11, 2019 It is also included in the full-text databases of the statistical source journals of Chinese scientific and technological papers and Chinese academic journals. The results showed that PMAS sublingual  can improve the symptoms of climacteric syndrome, regulate the level of estrogen and enhance the antioxidant capacity of the body.
Back to list